Methylation analysis of SFRP genes family in cervical adenocarcinoma.

J Cancer Res Clin Oncol

Department of Microbiology and Immunology, National Defense Medical Center, No. 161, Section 6, Min-Chuan East Road, Taipei 114, Taiwan.

Published: December 2009

AI Article Synopsis

  • Aberrant activation of the Wnt/beta-catenin signaling pathway is linked to human cancers, with SFRPs frequently showing methylation in cervical SCC, suggesting a potential role in tumor suppression.
  • The study examined the methylation status of SFRPs in cervical adenocarcinoma samples and found high levels of SFRP promoter hypermethylation compared to normal controls, indicating a significant correlation.
  • Reexpression of SFRP5 in cancer cell lines demonstrated its ability to suppress tumor characteristics and inhibit Wnt pathway downstream gene expression, highlighting its potential as a therapeutic target.

Article Abstract

Objectives: Aberrant activation of the Wnt/beta-catenin signaling pathway is common in human cancers. Recently, we have shown that secreted frizzled-related proteins (SFRPs) are frequently methylated in cervical squamous cell carcinoma (SCC). Furthermore, reexpression of SFRP1 and SFRP2 could suppress tumor cell transformation and invasion. Here, we want to further investigate the methylation status and function of SFRPs in adenocarcinoma of uterine cervix.

Methods: The methylation status of SFRPs was assessed in 23 adenocarcinomas (AC), and 45 normal control swabs by methylation-specific polymerase chain reaction and bisulfite sequencing. Then, we used reexpression of SFRP5 in cervical cancer cell lines, HeLa3rd and CaSki, to study the role of SFRP5 in cervical adenocarcinoma by colony formation and invasion assays. Finally, we checked whether SFRP5 could repress the expression of Wnt/beta-catenin downstream genes by quantitative reverse transcription-polymerase chain reaction.

Results: The frequency of SFRP genes promoter hypermethylation in adenocarcinoma of cervix samples was 52.2% (12/23), 82.6% (19/23), 65.2% (15/23), and 73.9% (17/23), for SFRP1, SFRP2, SFRP4, and SFRP5, respectively. The frequency of SFRP1, SFRP2, SFRP4, and SFRP5 promoter methylation in adenocarcinoma was significantly higher than in normal control samples (P < 0.001). Restoration of SFRP5 suppressed colony formation and invasive ability and inhibited expression of Wnt/beta-catenin downstream genes.

Conclusions: Our data suggest that promoter hypermethylation of SFRPs is associated with cervical adenocarcinoma, which could be used for molecular screening of cervical adenocarcinoma in the future. Moreover, SFRP5 inhibits cervical tumorigenesis through interfering Wnt pathway in vitro.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0613-5DOI Listing

Publication Analysis

Top Keywords

cervical adenocarcinoma
16
sfrp1 sfrp2
12
sfrp genes
8
methylation status
8
normal control
8
sfrp5 cervical
8
colony formation
8
expression wnt/beta-catenin
8
wnt/beta-catenin downstream
8
promoter hypermethylation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!